Key Transaction Details
The Preferential Issue Committee of Medicamen Biotech Limited approved the allotment of 5,00,000 Equity Shares through conversion of 5,00,000 Fully Convertible Warrants. The shares were issued at an issue price of ₹530 per equity share, resulting in an aggregate amount of ₹26,50,00,000 (₹26.50 crore).
Allottee Information
The allotment was made to Shivalik Rasayan Limited, which belongs to the 'Promoter and Promoter Group' category.
Capital Structure Impact
Consequent to the allotment, the Paid-up Equity Share Capital of the Company increased to ₹14,06,28,150 comprising 1,40,62,815 Equity Shares of face value ₹10 each.
Meeting Details
The Preferential Issue Committee meeting was held on October 23, 2026, commencing at 11:00 AM and concluding at 11:45 AM.